Oragenics review continues; plans for an IND by end-2026
Oragenics says it is reviewing certain items and remains focused on submitting an Investigational New Drug Application by the end of 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.